Beximco Pharmaceuticals Limited (AIM: BXP)
London flag London · Delayed Price · Currency is GBP · Price in GBX
37.50
-1.00 (-2.60%)
Jan 17, 2025, 12:00 PM GMT+1

Beximco Pharmaceuticals Market Cap

Beximco Pharmaceuticals has a market cap or net worth of 234.25 million as of January 22, 2025. Its market cap has decreased by -50.48% in one year.

Market Cap
234.25M
Enterprise Value
281.97M
Revenue
280.04M
Ranking
n/a
PE Ratio
6.31
Stock Price
37.50

Market Cap Chart

Since January 3, 2000, Beximco Pharmaceuticals's market cap has increased from 22.96M to 234.25M, an increase of 920.16%. That is a compound annual growth rate of 9.71%.

History

DateMarket Cap% Change
Jan 21, 2025234.25M-3.37%
Dec 30, 2024242.42M-48.09%
Dec 28, 2023466.99M-11.21%
Dec 29, 2022525.95M-29.56%
Dec 30, 2021746.62M1.29%
Dec 30, 2020737.12M192.11%
Dec 30, 2019 Pro Pro
Dec 27, 2018 Pro Pro
Dec 28, 2017 Pro Pro
Dec 29, 2016 Pro Pro
Dec 31, 2015 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
AstraZeneca 171.37B
GSK plc 55.43B
Haleon 33.25B
Smith & Nephew 9.04B
ConvaTec Group 4.92B
Hikma Pharmaceuticals 4.68B
HUTCHMED (China) 1.94B
Oxford Nanopore Technologies 1.48B
Market Cap Rankings